GE HealthCare price target raised to $94 from $84 at Piper Sandler

Piper Sandler raised the firm’s price target on GE HealthCare to $94 from $84 and keeps an Overweight rating on the shares. The firm notes the company reported Q4 results, with revenue and EPS finishing above consensus as three of the four segments contributed to strong top-line results and gross margin percentage moved nicely higher, while orders also grew better than most expected at +3% year-over-year.